Brighten Optix Corporation (TPEX:6747)
199.00
0.00 (0.00%)
At close: Nov 26, 2025
Brighten Optix Revenue
Brighten Optix had revenue of 216.97M TWD in the quarter ending September 30, 2025, a decrease of -5.45%. This brings the company's revenue in the last twelve months to 765.50M, up 2.60% year-over-year. In the year 2024, Brighten Optix had annual revenue of 766.93M with 2.63% growth.
Revenue (ttm)
765.50M
Revenue Growth
+2.60%
P/S Ratio
7.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 766.93M | 19.63M | 2.63% |
| Dec 31, 2023 | 747.30M | 3.03M | 0.41% |
| Dec 31, 2022 | 744.27M | 99.63M | 15.45% |
| Dec 31, 2021 | 644.64M | 103.58M | 19.14% |
| Dec 31, 2020 | 541.07M | 52.72M | 10.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |